Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.48 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.48 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.48 |
| ▸ | ALB | P02768 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | RARB | P10826 | 1/20 | 0.48 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24932635 | 0.86 | PTGS1 (0.47) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL12611228 | 0.80 | ALDH1A1 (0.44) | CA2CA4CA5A | |
| SCHEMBL24931502 | 0.80 | ESR1 (0.38) | ESR1TSHRCA2CA4CA5A | |
| SCHEMBL22623355 | 0.79 | PGK1 (0.55) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL17656768 | 0.77 | PTPRC (0.46) | PTGS1PTGS2ESR1HTR2ACA2 | |
| Hydrogen Peroxide SCHEMBL9581174 | 0.77 | PTGS1 (0.64) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL1131597 | 0.76 | PTGS1 (0.56) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL344618 | 0.76 | SMN1; SMN2 (0.52) | LMNATSHRCA2CA4CA5A | |
| SCHEMBL5667423 | 0.75 | CA2 (0.52) | LMNACYP2C9ESR1TSHRCA2 | |
| SCHEMBL13538582 | 0.75 | HDAC6 (0.40) | HTR2ATSHRCA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112852014-A | Asymmetric organic aromatic ligand metal salt nucleating agent and preparation method and application thereof | 华东理工大学 | 2021-05-28 | — | — | CN | claimed |
| US-20230117680-A1 | CYCLOPHILIN D INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-04-20 | — | — | US | disclosed |
| US-20230036933-A1 | HETEROCYCLIC INHIBITORS OF ENPP1 | VOLASTRA THERAPEUTICS, INC. (US) | 2023-02-02 | — | — | US | disclosed |
| CN-112852014-B | Asymmetric organic aromatic ligand metal salt nucleating agent and preparation method and application thereof | 华东理工大学 | 2022-03-15 | — | — | CN | disclosed |
| CN-112852014-A | Asymmetric organic aromatic ligand metal salt nucleating agent and preparation method and application thereof | 华东理工大学 | 2021-05-28 | — | — | CN | disclosed |
| US-9340660-B2 | Poly(3-hydroxyalkanoate) resin composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-17 | — | — | US | disclosed |
| EP-2479181-B1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | NISSAN CHEMICAL IND LTD (JP) | 2016-04-20 | — | — | EP | disclosed |
| EP-2431374-B1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | NISSAN CHEMICAL IND LTD (JP) | 2016-03-30 | — | — | EP | disclosed |
| CN-102482303-B | Method For Producing Metal Phosphonate And Thermoplastic Resin Composition Containing Metal Phosphonate | NISSAN CHEMICAL IND LTD | 2015-07-22 | — | — | CN | disclosed |
| US-9035100-B2 | Method for producing phenylphosphonic acid metal salt composition, and crystal nucleating agent therefrom | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-05-19 | — | — | US | disclosed |
| US-20140235771-A1 | POLY(3-HYDROXYALKANOATE) RESIN COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8445718-B2 | Method for producing phosphonic acid metal salt fine particles | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| EP-2479181-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | Nissan Chemical Industries, Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| CN-102482303-A | Method For Producing Metal Phosphonate And Thermoplastic Resin Composition Containing Metal Phosphonate | NISSAN CHEMICAL IND LTD | 2012-05-30 | — | — | CN | disclosed |
| EP-2431374-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | Nissan Chemical Industries, Ltd. (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20120046397-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| EP-1736510-B1 | POLYLACTIC ACID RESIN COMPOSITION | NISSAN CHEMICAL IND LTD (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110196077-A1 | PRODUCTION PROCESS OF PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
| US-7531585-B2 | Polyactic acid resin composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-05-12 | — | — | US | disclosed |
| EP-1736510-A1 | POLYLACTIC ACID RESIN COMPOSITION | Nissan Chemical Industries, Ltd. (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230036933-A1 | HETEROCYCLIC INHIBITORS OF ENPP1 | ENPP1, ENPP3, ENPP2 | PTGS1 708/4885PTGS2 1264/4885LMNA 3733/4885 |
| US-20110196077-A1 | PRODUCTION PROCESS OF PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | PPA1, PHOSPHO1, PRPS1 | PTGS1 688/4885PTGS2 1111/4885LMNA 4295/4885 |
| US-20120046397-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | PHOSPHO1, PLA2G2C, ACP1 | PTGS1 2325/4885PTGS2 2765/4885LMNA 2978/4885 |
| US-20230117680-A1 | CYCLOPHILIN D INHIBITORS AND USES THEREOF | PPID, PPIF, PPIL1 | PTGS1 185/4885PTGS2 1039/4885LMNA 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.